<DOC>
	<DOCNO>NCT00828087</DOCNO>
	<brief_summary>This study prospective , randomize control , single blind , two-arm , multi center clinical evaluation . A total 1500 patient enrol study . Patient randomization one two treatment arm : Everolimus arm Non drug elute stent arm . The objective study assess safety performance Everolimus Eluting Coronary Stent System versus modify cobalt chromium balloon expandable stent set primary percutaneous coronary intervention treatment patient present ST-segment elevation myocardial infarction .</brief_summary>
	<brief_title>A Clinical Evaluation Everolimus Eluting Coronary Stents Treatment Patients With ST-segment Elevation Myocardial Infarction : EXAMINATION Study</brief_title>
	<detailed_description>Primary PCI , without stenting , show result superior long-term outcome compare thrombolytic therapy patient acute myocardial infarction ( MI ) . Recently , several study show sirolimus- paclitaxel-eluting stent effective reduce restenosis frequency repeat intervention bare metal stent , rapidly result unrestricted use drug-eluting stent , also patient ST segment elevation MI ( STEMI ) . , , , Shortly introduction sirolimus-eluting stent April 2002 first study appear , hypothesize therapeutic range sirolimus-eluting stent could extend patient present MI . When compare bare metal stent , sirolimus-eluting stent associate less restenosis target vessel revascularization ( TVR ) one year follow-up . , At present , unclear whether also hold paclitaxel-eluting stents.4 , Everolimus sirolimus analogue , effective anti-proliferative agent inhibits growth factor-stimulated cell proliferation cause cell cycle arrest late G1 stage cell cycle . The objective study assess safety performance Everolimus Eluting Coronary Stent System versus modify cobalt chromium balloon expandable stent set primary percutaneous coronary intervention treatment patient present ST-segment elevation myocardial infarction . This study prospective , randomize control , single blind , two-arm , multi center clinical evaluation . A total 1500 patient enrol study . The primary endpoint combine endpoint Composite endpoint all-cause death , myocardial infarction revascularization 1 year ( patient orient endpoint suggest ARC definition ) . The following secondary endpoint examine : - All cause cardiac mortality 1 year yearly 5 year . - Recurrent myocardial infarction 1 year yearly 5 year . - Target lesion revascularization 1 year yearly 5 year . - Target vessel revascularization 1 year yearly 5 year . - Stent thrombosis ( accord new definition propose Academic Research Consortium ) 1 year yearly 5 year . - Clinical device success - Clinical procedure success . - Major minor bleed 1 year yearly 5 year .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Chromium</mesh_term>
	<mesh_term>Cobalt</mesh_term>
	<criteria>Patients present STelevation myocardial infarction must meet least one follow criterion Patients present STelevation myocardial infarction &lt; 12 hour onset symptom treat primary angioplasty + stent implantation Cardiogenic shock . Rescue PCI fail thrombolysis . PCI indicate early ( &lt; 24h ) effective thrombolysis follow current ESC guideline . Patients present late ( `` latecomer '' ) STelevation myocardial infarction ( &gt; 12h48h ) onset symptom . Written informed consent . The patient his/her family ( event patient clinically available ) accept clinical control . Angiographic : Vessel size range 2.254.0 mm visual estimation allow implantation currently available stent . Age &lt; 18 year . Pregnancy breastfeed . Known intolerance aspirin , clopidogrel , heparin , stainless steel , Everolimus , contrast material . Patients absolute indication chronic treat acenocoumarol Myocardial infarction due previously implant stent thrombosis Patients myocardial infarction require elective surgical coronary revascularisation within 1 year period ( example : inferior MI severe disease leave main surgical indication ) .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>acute myocardial infarction</keyword>
	<keyword>primary percutaneous coronary intervention</keyword>
	<keyword>drug-eluting stent</keyword>
</DOC>